Coming soon for patients taking XARELTO® (rivaroxaban): Janssen CarePath for XARELTO® and Janssen Select will transition to XARELTO withMe. We are simplifying access to our patient support in one location with a new name and look. Savings card and coverage gap benefits will not change.
What is XARELTO®?
XARELTO® belongs to a group of medicines called direct oral anticoagulants, or DOACs for short. Like other DOACs, XARELTO® has no known dietary restrictions and no requirements for frequent blood tests.
How does XARELTO® work?
XARELTO® slows your body's ability to clot by selectively blocking one of the clotting factors found in your blood—an enzyme called Factor Xa ("10a").
Reducing stroke risk with XARELTO®
XARELTO® is a prescription medication used to reduce the risk of stroke and blood clots in people with atrial fibrillation, not caused by a heart valve problem.
Over96%remained
stroke-free.*
stroke-free.*
Over96%remained stroke-free.*
In a clinical trial,
over 96% of people taking XARELTO® remained stroke-free.*
*Rate of first occurrence of stroke was 3.8% for XARELTO® versus 4.3% for warfarin.
Remember, all blood thinners come with a risk of bleeding. A clinical trial comparing XARELTO® to warfarin† for reducing the risk of AFib-related stroke showed that 99% of people taking XARELTO® did not experience bleeding into the brain, which can be serious. However, overall major bleeding was similar and gastrointestinal bleeding was about 1% higher.
†Coumadin® and Jantoven® are brand names for warfarin.